|
Previous: BIOJECT MEDICAL TECHNOLOGIES INC, S-8, 2000-10-26 |
Next: BIOJECT MEDICAL TECHNOLOGIES INC, S-8, EX-23.1, 2000-10-26 |
EXHIBIT 5.1
October 26, 2000
Board
of Directors
Bioject Medical Technologies, Inc.
7620 S.W. Bridgeport Road
Portland, Oregon 97224
We have acted as counsel for Bioject Medical Technologies, Inc., (the "Company") in connection with the filing of a Registration Statement on Form S-8 (the "Registration Statement") under the Securities Act of 1933, as amended, covering the issuance of 800,000 shares of common stock (the "Shares") of the Company pursuant to the Company's Restated 1992 Stock Incentive Plan (the "Plan"). We have reviewed the corporate actions of the Company in connection with this matter and have examined those documents, corporate records, and other instruments we deemed necessary for the purposes of this opinion.
Based on the foregoing, it is our opinion that:
We hereby consent to the filing of this opinion as an exhibit to the Registration Statement.
Very truly yours,
STOEL RIVES LLP
|